Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID)
Background
Previous studies assessing the prevalence of COVID-19 sequelae in adults and children were performed in the absence of an agreed definition. We investigated prevalence of post-COVID-19 condition (PCC) (WHO definition), at 6- and 12-months follow-up, amongst previously hospitalised adults and children and assessed risk factors.
Methods
Prospective cohort study of children and adults with confirmed COVID-19 in Moscow, hospitalised between April and August, 2020. Two follow-up telephone interviews, using the International Severe Acute Respiratory and Emerging Infection Consortium survey, were performed at 6 and 12 months after discharge.
Results
One thousand thirteen of 2509 (40%) of adults and 360 of 849 (42%) of children discharged participated in both the 6- and 12-month follow-ups. PCC prevalence was 50% (95% CI 47–53) in adults and 20% (95% CI 16–24) in children at 6 months, with decline to 34% (95% CI 31–37) and 11% (95% CI 8–14), respectively, at 12 months. In adults, female sex was associated with PCC at 6- and 12-month follow-up (OR 2.04, 95% CI 1.57 to 2.65) and (OR 2.04, 1.54 to 2.69), respectively. Pre-existing hypertension (OR 1.42, 1.04 to 1.94) was associated with post-COVID-19 condition at 12 months. In children, neurological comorbidities were associated with PCC both at 6 months (OR 4.38, 1.36 to 15.67) and 12 months (OR 8.96, 2.55 to 34.82) while allergic respiratory diseases were associated at 12 months (OR 2.66, 1.04 to 6.47).
Conclusions
Although prevalence of PCC declined one year after discharge, one in three adults and one in ten children experienced ongoing sequelae. In adults, females and persons with pre-existing hypertension, and in children, persons with neurological comorbidities or allergic respiratory diseases are at higher risk of PCC.
Топ-30
Журналы
|
1
2
3
4
5
6
|
|
|
medRxiv
6 публикаций, 7.41%
|
|
|
Frontiers in Immunology
3 публикации, 3.7%
|
|
|
BMC Public Health
3 публикации, 3.7%
|
|
|
International Journal of Environmental Research and Public Health
2 публикации, 2.47%
|
|
|
EClinicalMedicine
2 публикации, 2.47%
|
|
|
Pediatric Pulmonology
2 публикации, 2.47%
|
|
|
PLoS ONE
2 публикации, 2.47%
|
|
|
Current Opinion in Pediatrics
1 публикация, 1.23%
|
|
|
Journal of the Association of Medical Microbiology and Infectious Disease Canada
1 публикация, 1.23%
|
|
|
Diseases
1 публикация, 1.23%
|
|
|
SN Comprehensive Clinical Medicine
1 публикация, 1.23%
|
|
|
Journal of Infection and Public Health
1 публикация, 1.23%
|
|
|
JAMA Internal Medicine
1 публикация, 1.23%
|
|
|
International Journal of Infectious Diseases
1 публикация, 1.23%
|
|
|
Zeitschrift fur Gesundheitswissenschaften
1 публикация, 1.23%
|
|
|
Biology Bulletin Reviews
1 публикация, 1.23%
|
|
|
Pediatric Allergy and Immunology
1 публикация, 1.23%
|
|
|
American Journal of Epidemiology
1 публикация, 1.23%
|
|
|
Clinical and Experimental Dermatology
1 публикация, 1.23%
|
|
|
Frontiers in Sociology
1 публикация, 1.23%
|
|
|
JMIR Research Protocols
1 публикация, 1.23%
|
|
|
Cytokine
1 публикация, 1.23%
|
|
|
Pediatrics
1 публикация, 1.23%
|
|
|
Molecular Psychiatry
1 публикация, 1.23%
|
|
|
European Journal of Internal Medicine
1 публикация, 1.23%
|
|
|
Frontiers in Pediatrics
1 публикация, 1.23%
|
|
|
Clinical and Experimental Allergy
1 публикация, 1.23%
|
|
|
Hypertension Research
1 публикация, 1.23%
|
|
|
World Journal of Pediatrics
1 публикация, 1.23%
|
|
|
1
2
3
4
5
6
|
Издатели
|
2
4
6
8
10
12
14
16
18
|
|
|
Springer Nature
17 публикаций, 20.99%
|
|
|
Elsevier
9 публикаций, 11.11%
|
|
|
Wiley
8 публикаций, 9.88%
|
|
|
Frontiers Media S.A.
7 публикаций, 8.64%
|
|
|
Oxford University Press
6 публикаций, 7.41%
|
|
|
openRxiv
6 публикаций, 7.41%
|
|
|
MDPI
3 публикации, 3.7%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 публикации, 2.47%
|
|
|
American Medical Association (AMA)
2 публикации, 2.47%
|
|
|
Public Library of Science (PLoS)
2 публикации, 2.47%
|
|
|
Taylor & Francis
2 публикации, 2.47%
|
|
|
BMJ
2 публикации, 2.47%
|
|
|
SAGE
2 публикации, 2.47%
|
|
|
University of Toronto Press Inc. (UTPress)
1 публикация, 1.23%
|
|
|
Pleiades Publishing
1 публикация, 1.23%
|
|
|
JMIR Publications
1 публикация, 1.23%
|
|
|
American Academy of Pediatrics
1 публикация, 1.23%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 1.23%
|
|
|
Research Square Platform LLC
1 публикация, 1.23%
|
|
|
Medknow
1 публикация, 1.23%
|
|
|
Media Sphere Publishing House
1 публикация, 1.23%
|
|
|
Cambridge University Press
1 публикация, 1.23%
|
|
|
Central Research Institute for Epidemiology
1 публикация, 1.23%
|
|
|
F1000 Research
1 публикация, 1.23%
|
|
|
Scientific Scholar
1 публикация, 1.23%
|
|
|
Publishing House ABV Press
1 публикация, 1.23%
|
|
|
2
4
6
8
10
12
14
16
18
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.